The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Merck & Co ("Merck" or the "Company") .

The U.S. CDC plans to embark on a large study into potential connections between vaccines and autism, despite extensive scientific research ...

Wall Street stocks were in the red early on Friday as investors digested last month's all-important non-farm payrolls report.

Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising ...

Full Year 2024 Results Key Financial Results Revenue: €21.2b (flat on FY 2023). Net ...

Merck posted strong Q4 earnings, with a 7% revenue increase to $15.62 billion, beating expectations. Growth was driven by ...

ImmunityBio (IBRX) faces operational, financial, and competitive challenges, impacting its growth prospects despite Anktiva's ...

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and ...

Merck (MRK) ended the recent trading session at $94, demonstrating a +0.87% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily loss of 1.78%. Meanwhile, ...